ADBE enters its September 10 earnings window with short sellers on the back foot — the stock up 17% over the past month and bears quietly covering — yet analyst camps remain sharply divided on where the recovery goes from here.
The most concrete change in positioning this week is a short sellers stepping away. Short interest has dropped 6% over the past week and over 8% across the month, pulling the float-short figure down to 4.3% — its lowest level in the 30-day window. The bulk of that cover happened in a single session on August 24, when roughly one million shares were returned, followed by further reductions through the rest of the week. That pace of covering coincides almost exactly with the stock's run from $245 to $291, a classic pattern of shorts closing into price strength. Borrowing costs nudged up about 59% on the week in percentage terms, but that figure overstates the drama — cost to borrow remains at just 0.41%, firmly in the "easy to borrow" category. Availability in the lending pool is extraordinarily loose, running above 4,700% of current short interest, meaning there is no friction whatsoever for new shorts to enter if conviction returns. Options tell a modestly more cautious story: the put/call ratio has climbed to 0.67, roughly 1.3 standard deviations above its 20-day average of 0.60, and has drifted steadily higher all month. That is not an extreme reading — the 52-week high is 0.99 — but the direction of travel suggests some investors are buying downside protection into the print.
The Street picture is the most interesting tension in the name. The consensus is fragmented in a way that rarely resolves cleanly. BofA Securities maintained an Underperform rating earlier this month while lifting its target to $220 — still 25% below where the stock is trading. Morgan Stanley downgraded ADBE to Underweight in July, cutting its target from $365 to $240, a move that now looks premature given the subsequent rally. On the other side, HSBC upgraded to Buy in early July with a $308 target, and CLSA initiated at Outperform with a $300 target. The consensus mean target from the analyst data sits near $271, which is actually below the current price of $291 — a configuration that puts the burden of proof squarely on the bulls. JPMorgan is an outlier on the constructive side at $340, maintaining Overweight even after trimming its target post-June earnings. Goldman Sachs remains a Sell at $190. That $150 spread between the highest and lowest credible targets reflects a genuine disagreement about the company's AI positioning, not just valuation quibbling.
The bear case has real substance. June's earnings print knocked the stock 12.6% in a single day and 16.4% over the following week — the most damaging one-two combination in recent history. The concern then was Adobe's decision to prioritize MAU growth over near-term monetization through its freemium pivot, alongside the CFO departure and questions about succession at the CEO level. The bull case rests on ARR trajectory and Adobe's structural grip on the creative workflow, with CLSA and JPMorgan arguing that the competitive displacement narrative is overdone. Factor scores offer modest support for the latter view: EV/EBIT ranks in the 76th percentile across the universe, and the days-to-cover rank sits at 61, reflecting manageable short-side interest. EPS momentum is softer — the 30-day reading at the 41st percentile, improving to 62 on a 90-day basis — suggesting estimate revisions have stabilized but not accelerated.
Institutional positioning is broadly passive and stable. BlackRock holds 10.4% of shares, Vanguard entities collectively another 9.6%, and State Street 5.2%. None of the top holders show material reduction. Insider activity has been noise-level — the CFO received an award and sold a token 28 shares on August 14; the Chief Accounting Officer made a small open-market sale in late July. Nothing in the insider data signals either conviction or alarm. Peer context worth noting: CRM jumped 22% on the week while NOW added 13%, suggesting broad software sentiment was a tailwind for ADBE's 6% weekly gain rather than anything Adobe-specific. ADSK bucked that trend, down 3.7% on the day of writing, underscoring that not all design-adjacent software names are catching the same bid.
September 10 is the next hard event — whether Adobe's freemium user numbers are translating into the ARR reacceleration bulls need, or whether the monetization gap widens further, will determine whether the short-covering of the past month was prescient or premature.
See the live data behind this article on ORTEX.
Open ADBE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
